June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Chronic Ocular GVHD Treatments at Two Distinct Geographic Locations of a Single Tertiary Referral Center
Author Affiliations & Notes
  • Muhammad Bilal Qureshi
    Mayo Clinic Alix School of Medicine, Mayo Foundation for Medical Education and Research, Scottsdale, Arizona, United States
  • Jose Omar Garcia
    Mayo Clinic Alix School of Medicine, Mayo Foundation for Medical Education and Research, Scottsdale, Arizona, United States
  • Jaxon Quillen
    Department of Quantitative Health Sciences, Mayo Foundation for Medical Education and Research, Scottsdale, Arizona, United States
  • Carolyn Mead-Harvey
    Department of Quantitative Health Sciences, Mayo Foundation for Medical Education and Research, Scottsdale, Arizona, United States
  • Christina Wentz
    Illinois College of Optometry, Chicago, Illinois, United States
  • Cherie B Nau
    Department of Ophthalmology, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Muriel Schornack
    Department of Ophthalmology, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Joanne Shen
    Department of Ophthalmology, Mayo Foundation for Medical Education and Research, Scottsdale, Arizona, United States
  • Footnotes
    Commercial Relationships   Muhammad Qureshi None; Jose Garcia None; Jaxon Quillen None; Carolyn Mead-Harvey None; Christina Wentz None; Cherie Nau None; Muriel Schornack None; Joanne Shen None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3980 – A0260. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Muhammad Bilal Qureshi, Jose Omar Garcia, Jaxon Quillen, Carolyn Mead-Harvey, Christina Wentz, Cherie B Nau, Muriel Schornack, Joanne Shen; Chronic Ocular GVHD Treatments at Two Distinct Geographic Locations of a Single Tertiary Referral Center. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3980 – A0260.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Examine differences in baseline characteristics and treatment of chronic ocular graft versus host disease (oGVHD) patients in two geographically distinct locations.

Methods : Patients diagnosed with definite chronic oGVHD as defined by the International Chronic Ocular GVHD Consensus Group between 09/2014 and 09/2021 at two locations were identified. Clinic 1 (C1) is located in Arizona and Clinic 2 (C2) is located in Minnesota. IRB approved retrospective chart review was conducted and the following data was collected for initial and follow-up visits: demographic information, ocular surface disease index (OSDI), corneal fluorescein staining (CFS), and treatment (hot compresses, moisture chambers, punctal plugs, punctal cautery, autologous serum tears (AST), and scleral contact lenses). Differences by site were tested using Chi-Square tests or linear model ANOVA.

Results : C1 (n=79) and C2 (n=50) baseline mean age was 58.4 years and 57.5 years, respectively. Mean length of follow-up was 108.2 weeks for C1 and 115.9 weeks for C2. By last follow-up, mean OSDI change was -17.6 at C1 (95% CI -24.2, -11.1) and +5.3 (95% CI -1.4, 12.1) at C2. The difference in changes was statistically significant (p<0.001). At baseline, C1 mean CFS was significantly worse for both eyes than C2 mean CFS (OD p=0.012, OS p<0.001). By last follow-up, mean CFS OD change was -0.5 at C1 (95% CI -0.7, -0.2) and -0.1 (95% CI -0.4, 0.2) at C2. The mean CFS OS change was -0.5 (95% CI -0.7, -0.2) at C1 and +0.1 (95% CI -0.2, 0.4) at C2. The difference in changes was statistically significant for CFS OS (p=0.006) but not for CFS OD (p=0.130). Moisture chambers and scleral lenses were used in similar frequencies at C1 and C2 (14% vs 18%, 16% vs 18%, respectively). However, punctal plugs, punctal cautery, and AST were used more frequently at C1 than C2 (85% vs 60%, 67% vs 26%, 52% vs 8%, respectively).

Conclusions : oGVHD patients at C1 were associated with significant improvement in OSDI and corneal fluorescein staining in the left eye and were also associated with more frequent use of punctal plugs, cautery, and AST. The significance of these associations is limited by the retrospective nature of this review. Greater severity of baseline CFS at C1 supports previous studies showing that desert climate is associated with more severe signs of dry eye. Future prospective studies are needed to confirm the validity of these findings.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×